Dimerix Limited reported earnings results for the half year ended December 31, 2023. For the half year, the company reported net loss was AUD 6.67 million compared to AUD 9.61 million a year ago. Basic loss per share from continuing operations was AUD 0.01645 compared to AUD 0.02995 a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.325 AUD | -1.52% | -7.14% | +58.54% |
05-01 | Dimerix Secures Pediatric Plan Approval in the UK for Kidney Disease Medication | MT |
04-22 | Dimerix Posts AU$35.2 Million Cash, AU$3.3 Million Operating Cash Outflows for March Quarter | MT |
1st Jan change | Capi. | |
---|---|---|
+58.54% | 120M | |
+17.96% | 44.96B | |
+1.17% | 42.65B | |
+46.56% | 41.85B | |
-4.27% | 29.04B | |
+11.42% | 26.08B | |
-21.39% | 19.03B | |
+4.86% | 12.75B | |
+27.29% | 12.06B | |
-3.50% | 11.75B |
- Stock Market
- Equities
- DXB Stock
- News Dimerix Limited
- Dimerix Limited Reports Earnings Results for the Half Year Ended December 31, 2023